Hemophagocytic syndrome in adults;Syndrome d'activation macrophagique de l'adulte

Hematologie

Volumn 4, Issue 5, 1998, Pages 374-380

  Larroche, Claire ^a  

^a FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE ASSOCIATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOPATHOGENESIS; MORTALITY; PATHOPHYSIOLOGY; REVIEW;

EID: 0031795243     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Farquhar JW, Claireaux AE. Familial hemophagocytic reticulosis. Arch Dis Child 1952 ; 27 : 519-25.
2. Chandra P, Chaudhery SA, Rosner F, Kagen M. Transient histiocytosis with striking phagocytosis of platelets, leukocytes, and erythrocytes. Ann Intern Med 1975 ; 135 : 989-91.
3. Mongkonsritragoon W, Li CY, Phyliky R. True malignant histiocytosis. Mayo Clin Proc 1998 ; 73 : 520-8.
4. Reiner AP. Hematophagic histiocytosis. Medicine 1988 ; 67 : 369-88.
5. Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinelli M, Rusca MP. Hemophagocytic lymphohistiocytosis. Report of 122 children from the international registry. Leukemia 1996 ; 10 : 197-203.
6. Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis with viral infections. Acta Paediatr 1993 ; 82 : 369-72.
7. Imashuku S, Ikushima S, Hibi S, Todo S. Langerhans cell histiocytosis and hemophagocytic syndrome in Japan ; epidemiological studies, Int J Pediatr Hematol Oncol 1994 ; 1 : 241-6.
8. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in heathy adults. Br J Haematol 1995 ; 89 : 923-6.
9. Stéphan F. Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 1997 ; 25 : 1159-64.
10. Fléchaire A. Les syndromes hémophagocytaires. Rev Med Interne 1996 ; 17 : 157-62.
11. Favara BE. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997 ; 29 : 157-66.
12. Ohga S. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993 ; 15 : 291-8.
13. Sailler L, Duchayne E, Marchou B, Brousset P, Pris J, Massip P, Corberand J, Arlet P. Aspects étiologiques des hémophagocytoses réactionnelles : étude rétrospective chez 99 patients. Rev Med Interne 1997 ; 18 : 855-64.
14. Hibi S. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995 ; 75 : 1700-5.
15. Komp DM, Buckley PJ, McNamara J, Van Hoff J. Soluble interleukin-2 receptor in hemophagocytic histiocytoses, searching for markers of disease activity. Pediatr Hematol Oncol 1989 ; 6 : 253.
16. Akashi K. Involvement of interferon-γ and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Hematol 1994 ; 87 : 243-50.
17. Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, Tsunematsu Y. Soluble interleukin 2 receptor : a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995 ; 86 : 4706-7.
18. Osugi Y. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997 ; 89 : 4100-3.
19. Egeler RM, Shapiro R, Loechelt B, Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996 ; 18 : 340-5.
20. Eife R, Janka GE, Belohradsky BH, Holtmann H. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 1989 ; 6 : 265-72
21. Kataoka Y, Todo S, Morioka Y, Sugie K, Nakamura Y, Yodoi J, Imashuku S. Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis Cancer 1990 ; 65 : 1937-41.
22. Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S, Sano K. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia Blood 1998 ; 91 : 2793-9.
23. Henter JI, Andersson B, Elinder G, Jakobson A, Lübeck PO, Söder O. Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonist in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1996 ; 27 : 21-5.
24. Tsuda H. Hemophagocytic syndrome in children and adults Int J Hematol 1997 ; 65 : 215-26
25. Tiab M, Mechinaud F, Hamidou M, Gaillard F, Raffi F, Harousseau JL. Syndromes hémophagocytaires, une série de 23 observations. Ann Med Interne 1996 ; 147 : 138-44.
26. Albert A, Azgui Z, Buisine J, Ciaudo M, Fenneteau O, Fillola G, Lasserre M, Merle-Béral H, Mielot F, Raphael M. Macrophage activation syndromes. Nouv Rev Fr Hematol 1992 ; 34 : 435-41.
27. Tsuda H, Shirono K. Serum lipids in adult patients with hemophagocytic syndrome. Am J Hemotol 1996 ; 53 : 285.
28. Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S. High serum ferritin levels as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1988 ; 61 : 2071-6.
29. Wong KF, Chan JKC. Reactive hemophagocytic syndrome, a clinicopathologic study of 40 patients in an Oriental population. Am J Med 1992 ; 93 : 177-80.
30. Henter JI. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991 : 18 : 29-33
31. Imashuku S. Differential diagnosis of hemophagocytic syndrome : underlying disorders and selection of the most effective treatment. Int J Hematol 1997 ; 66 : 135-51.
32. Tsuda H. The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults. Leuk Lymphoma 1997 ; 28 : 73-82.
33. Imashuku S, Ikushima S, Esumi N, Todo S, Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukine-2 receptor in childhood hemophagocytic syndromes. Leuk Lymphoma 1991 ; 3 : 287-92.
34. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993 ; 15 : 92-8.
35. Imashuku S, Hibi S, Fujiwara F, Todo S. Hyper-interleukin-6-naemic in haemophagocytosis lymphohistiocytosis. Br J Haematol 1996 ; 93 : 803-7.
36. Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Sakamoto M, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Hosoya T. Prognostic factors of hemophagocytic syndrome in adults : analysis of 34 cases, Eur J Haematol 1997 ; 59 : 247-53.
37. Bird G, Peel D, McCarthy K, Williams H. Epstein-Barr virus induced virus-associated hemophagocytic syndrome and monoclonal TCR-beta rearrangement : a case report. Hematol Oncol 1997 ; 14 : 47-52.
38. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai, Kobayashi N, Mizutani S. Epstein-Barr virus infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993 ; 92 : 1444-50.
39. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997 ; 130 : 352-7.
40. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in EBV-associated T-lymphoproliferative disorders : disease spectrum, pathogenesis, and management. Leuk Lymphoma 1995 ; 19 : 401-6.
41. Chen JS, Tzeng CC, Tsao CJ, Su WC, Chen TY, Jung YC, Su IJ. Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica 1997 ; 82 : 572-6.
42. Kaneko Y, Maseki N, Sakurai M, Ido M, Tsunematsu Y, Mizutani S, Hattori T, Shimizu H, Eguchi H, Oka T, Miyake, Horikoshi Y, SuchiT. Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis. Br J Haematol 1995 ; 90 : 48-55.
43. + natural killer cell-type malignancy resembling malignant histiocytosis : malignant transformation in chronic active EBV infection associating hypogammaglobulinemia. Pathol Int 1997 ; 47 : 384-92.
44. Okano M, Gross TG. EBV-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996 ; 53 : 111-5.
45. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor a gene by EBV and activation of macrophages in EBV-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997 ; 100 : 1969-79.
46. Purtilo DT, Cassel CK, Yang JPS, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975 ; 1 : 935-40.
47. Grierson H, Purtilo DT Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987 ; 106 : 538-45
48. Takagi M, Unno A, Maruyama T, Kaneko K, Obinata K. Human herpesvirus-6 associated hemophagocytic syndrome Pediatr Hematol Oncol 1996 ; 13 : 451-6.
49. Ambruso DR, Hays T, Zwartjes WJ, Tubergen DG, Favara BE. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer 1980 ; 45 : 2516-20.
50. Omagori K, Ashida R, Oh-l H, Minamino Y, Sasaki O, Ozono Y, Maeda T, Sadamori N, Tomonaga M, Kohno S. Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. Am J Med Sci 1997 , 314 : 403-7.
51. Stéphan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993 ; 8 : 2319-23.
52. Ladisch S, Ho W, Matheson D, Pilkington R, Hartman G. Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood 1982 ; 60 : 814-21.
53. Gill DS, Cobcroft S & RG. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994 ; 88 : 204-6.
54. Freeman B, Rathore MH, Salmon E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993 ; 123 : 479-81.
55. Chen RL, Lin KH, Lin DT, Su IJ, Huang LM, Lee PI, Hseih KH, Lin KS, Lee CY. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995 ; 89 : 282-90.
56. Bourquelot P, Oksenhendler E, Wolff M, Fegueux S, Piketty C, d'Agay MF, Clauvel JP. Syndrome d'hémophagocytose au cours de l'infection par le VIH. Presse Med 1993 ; 22 : 1217-20.